Mitochon Pharmaceuticals, Inc. — Form D/A
Mitochon Pharmaceuticals, Inc. of RADNOR, PA, a company, filed a Form D amendment with the SEC on 2016-04-29. The offering totals $700K, of which $425K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-04-29
- Form: D/A
- Accession: 0001627113-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $700K
- Amount sold: $425K
- Remaining: $275K
- Minimum investment: $25K
- Investors: 5
- Date of first sale: 2016-04-15
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-262287
Issuer
- Name: Mitochon Pharmaceuticals, Inc.
- CIK: 0001627113
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 259 NORTH RADNOR CHESTER RD, SUITE 210, RADNOR, PA, 19087
- Phone: 215-313-3905
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Robert Alonso | Director | Radnor, PA |
| John Geisler | Director | EAGAN, MN |
| John Irwin | Director | New York, NY |
| Robert Alonso | Executive Officer | Radnor, PA |
| Peter Crooks | Executive Officer | Radnor, PA |
| John Geisler | Executive Officer | EAGAN, MN |
Other filings by this issuer (2)
More